Valneva SE VALN
NASDAQ VALN
$6.91 -0.15 (-2.20%)
As of: Sep 4, 2026 · 3:14 PM EDT

Valneva SE (VALN) Cash & Equivalents (2019 - 2026)

Valneva SE (VALN) posted Cash & Equivalents of $123.2 million for Q1 2026, down 3.45% sequentially from $127.6 million in Q4 2025, and down 23.42% YoY from $160.9 million in Q1 2025.

Analysis

Valneva SE (VALN) Cash & Equivalents (2019 - 2026) Analysis & Trends

Valneva SE has reported Cash & Equivalents for 8 years, with the latest figure at $123.2 million in Q1 2026.

  • Quarterly Cash & Equivalents fell 23.42% year-over-year to $123.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $123.2 million (down 23.42% YoY) and the FY2025 annual result came in at $127.6 million, down 29.92% from the prior year.
  • Cash & Equivalents declined to $123.2 million in Q1 2026 per VALN's latest filing, from $127.6 million in the prior quarter.
  • Over five years, Cash & Equivalents peaked at $358.8 million in Q2 2022 and troughed at $123.2 million in Q1 2026.
  • A 5-year average of $207.6 million and a median of $182.6 million in 2025 frame the typical range for Cash & Equivalents.
  • The sharpest annual moves came in 2022 and 2023: Cash & Equivalents surged 638756.95% in 2022, then tumbled 53.6% in 2023.
  • Over 5 years, Cash & Equivalents stood at $292.3 million in 2022, then sank by 53.6% to $135.7 million in 2023, then surged by 32.55% to $179.8 million in 2024, then dropped by 29.02% to $127.6 million in 2025, then dropped by 3.45% to $123.2 million in 2026.
  • According to Business Quant data, Cash & Equivalents over the past three periods registered $123.2 million, $127.6 million, and $167.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 Vertex Pharmaceuticals 138.43 Bn 130.58 Bn 2.84 Bn 6.14 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 2.46 Bn
3 Argenx Se 63.34 Bn 58.15 Bn 1.37 Bn 3.58 Bn
4 Moderna 57.98 Bn 52.85 Bn 52.00 Mn 1.72 Bn
5 Revolution Medicines 43.98 Bn 43.98 Bn - 815.44 Mn
6 BeOne Medicines 39.92 Bn 34.82 Bn 1.53 Bn 5.10 Bn
7 Alnylam Pharmaceuticals 35.42 Bn 32.11 Bn 992.69 Mn 1.71 Bn
8 Royalty Pharma 28.42 Bn 27.58 Bn - 811.99 Mn
9 Insmed 27.36 Bn 26.20 Bn 358.27 Mn 544.80 Mn
10 Valneva SE 580.64 Mn 439.38 Mn 1.86 Mn 141.26 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 141.26 Mn
Mar 31, 2026 123.24 Mn
Dec 31, 2025 127.64 Mn
Sep 30, 2025 167.71 Mn
Jun 30, 2025 182.59 Mn
Mar 31, 2025 160.93 Mn
Dec 31, 2024 179.81 Mn
Sep 30, 2024 171.69 Mn
Jun 30, 2024 141.52 Mn
Mar 31, 2024 191.89 Mn
Dec 31, 2023 135.65 Mn
Sep 30, 2023 186.42 Mn
Jun 30, 2023 222.59 Mn
Mar 31, 2023 273.15 Mn
Dec 31, 2022 292.33 Mn
Sep 30, 2022 263.20 Mn
Jun 30, 2022 358.77 Mn
Mar 31, 2022 349.34 Mn
Dec 31, 2021 45,758.84
Sep 30, 2021 292.40 Mn